Detecting the Tumor: How Non-invasive Diagnostic Testing is Shaping the Future of Neuro-oncology

Date/Time: Tuesday, October 25, 2022 - 11:00 AM – 12:30 PM
Track: Traditional Special Interest Group
Log in to Add to My Schedule


Learning Objectives:

Following this session, learners will increase their understanding of non-invasive diagnostic testing in the evaluation of CNS tumors including: 1) The detection and utility of circulating tumor cells and circulating tumor DNA in primary CNS tumors and metastases, and 2) Applications of artificial intelligence and deep learning. 

Chair: Megan Mantica, MD

Co-Chair: Kevin Elmore, MD 

Circulating Tumor DNA and Primary CNS Tumors


Cerebrospinal Fluid Circulating Biomarkers in Patients with Central Nervous System Tumours


Deep Learning in Glioma Imaging


Gray Matter Alteration in Cancer Survivors After Chemotherapy: An ALE Meta-Analysis of Voxel-Based Morphometry Studies

Poster Presenter: Yaman Ahmed, MD, Jordan University of Science and Technology

Oncogenic Long Non-Coding RNA LINC02283 Enhances PDGF Receptor A Mediated Signaling and Drives Glioblastoma Tumorigenesis

Poster Presenter: Anshika Goenka, MD, PhD, Northwestern University